Jo – Interview 32
Jo’s son experiences severe migraines. In 2009 she was invited to enroll her son in a randomised placebo controlled trial for the treatment of migraine in children. Jo gave her consent although she was initially concerned about the trial and the treatment.
Jo is aged 28 years, married and is a full time housewife. Jo has two children. Her eldest son Daniel is aged 8 years and has experienced severe headaches since he was two years old. He would often scream at night. At the time Jo thought this was nightmares. As he got older he would complain of severe bellyache; and was sick for hours on end;. Jo took her son to the doctors and it was first thought that Daniel might be experiencing some sort of food allergy. She was advised to give him Calpol. Dan was experiencing at least one migraine a month and was unable to move, eat and drink for at least 24 hours. Eventually at the age of seven Daniel was referred to the hospital. Again she was advised to give her son Calpol. However, Jo was not happy as he was getting worse. After a second appointment at the hospital she received a call the following day to see if she would be interested to enroll her son in randomised placebo controlled trial. At the time they were very skeptical of putting him in a trial testing medication that they didn’t know and didn’t know what the side effects could be.
Jo and her husband agreed to meet the doctor and nurses at the hospital to get an idea of what the trial was about. Jo says she wanted to know If it could help him, how long he;d be on the tablets for, what would happen after the trail finished, would he then have specialist help Her main concern was her family history of migraine as she knew how migraine could affect someone and she did not want this for her son. Making the decision was not easy. However, the doctor and nurses were very understanding and explained everything to them and how important it was to find a treatment that suited Daniel. She says They made Daniel feel special It was this approach that swayed them to agree to enroll Daniel in the trial in the hope that it would help him and others.
Neither Jo nor the doctors and nurses know whether Daniel has received a drug or a placebo. Daniel is still in the trial. Jo is pleased to have enrolled her son as he seems to be better and has had fewer migraines. Her only concern is that Daniel has to remain on medication for the rest of his life. One thing that Jo did find hard during the trial was remembering to remind her son to take the tablets. Based on her experience and how supportive the doctors and nurses have been she would certainly consider taking part in another clinical trial in the future.